In an effort to study whether human cytomegalovirus (HCMV) can disrupt the balanced cytokine network that controls human hematopoiesis, we investigated the ability of a laboratory strain HCMV (AD1 69) to alter the production of interleukin-6 (IL-6) by cultured endothelial cells (HUVECs). ECs are important components of human bone marrow stroma and produce factors that stimulate the proliferation and differentiation of human hematopoietic progenitors. HCMV was able to greatly increase production of both mRNA and protein for IL-6 in unprimed HUVECs. When we discriminated between viral pellet and cleared viral supernatants, the supernatants induced an in-NDOTHELIAL CELLS (ECs) are recognized components of human bone marrow (BM) stromal-3 and produce factors that stimulate the proliferation and differentiation of human hematopoietic progenitor^.^-^ Given the intimate proximity within this closed microenvironment, even minute changes in the production of cytokines by BM ECs could have deleterious effects on the closely regulated hematopoietic process.
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Interleukin-6 (IL-6) is a cytokine that is produced by many diverse cell types and exerts multiple biologic activities either alone or in conjunction with other cytokines.'.' IL-6 regulates immune responses, hematopoiesis, and acute phase reactions, playing a central role in the host defense Previously, it has been shown that several viruses are capable of activating the IL-6 promoter in a variety of cell types.13 Also, abnormal expression of IL-6 is directly related with the pathogenesis of several diseases. I4-l6 Because ECs are also known producers of this growth and human cytomegalovirus (HCMV) infection is one of the most serious complications in BM transplant, often resulting in p a n~y t o p e n i a ,~~-'~ this study was undertaken to investigate the effect of HCMV infection on the production of IL-6 by cultured human umbilical vein ECs (HUVECs). Our results show that HCMV can cause a perturbation of the cytokine cascades involved in the regulation of hematopoiesis, in particular the production of IL-6 by ECs.
crease in mRNA at 30 minutes and protein by 2 hours, whereas an increase in IL-6 caused by virus itself did not become evident until 1 2 hours. The possibility that IL-6 induction was simply caused by the presence in the viral stock of endotoxin, IL-la, IL-l& tumor necrosisfactora, or IL-4, all known inducers of IL-6 in HUVECs, was ruled out by the addition of polymyxin B and appropriate neutralizing antibodies. These findings show that HCMV is capable of directly and indirectly modulating the production by HUVECs of IL-6, one of the cytokines involved in the process of hematopoiesis.
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MATERIALS AND METHODS
Cell culture. Human ECs were harvested from umbilical cord veins as described previously.*' The cells were cultured in gelatincoated (DIFCO Laboratories, Detroit, MI) flasks (Costar, Cambridge, MA) in medium MI99 (M.A. Bioproducts, Bethesda, MD), supplemented with 15% heat-inactivated fetal bovine serum (FBS; GIBCO Laboratories, Grand Island, NY), 50 pg/mL heparin (Sigma Chemical CO, St Louis, MO), 30 pg/mL EC growth factor (Chemicon, Temecula, CA), and antibiotics. All culture reagents were free of detectable endotoxin contamination as assessed by Limulus test (sensitivity 0.05 to 0.1 endotoxin units per milliliter; Sigma). All experiments were performed with confluent third or fourth passage HUVECs plated in I O mL of medium on 100-mm petri dishes (Corning, Corning, NY). Each series ofexperiments was performed on cultures from pools of 5 different umbilical cords. All cell cultures were mycoplasma-free as judged by the MycoRuor Mycoplasma Detection Kit (Molecular Probes, Inc, Eugene, OR). The EC origin of all cell cultures was confirmed by FACScan analysis (Becton Dickinson, San Jose, CA) of cells stained with the EN4 antibody (Vec Tec Inc, Schenectady, NY) (298% staining). Cytokines, viruses, and others mediators were added for the times and at the concentrations indicated below.
Supernatants were harvested and centrifuged to remove cell debris and frozen at -20°C until analyzed. Cycloheximide (Sigma) was added at a concentration of 10 p d m L when indicated 1 hour before infection and maintained until analysis of the samples was performed.
Viral infiction ofECs. Twenty-four hours after passage, EC media was removed from the cultures, and changed to 15% FBS Iscove's modified Dulbecco's medium (IMDM; M.A. Bioproducts), 8 mmol/L sodium butyrate (Sigma) for the next 24 hours, after which the cells were infected with CMV (AD1 69 strain) at a multiplicity of infection (MOI) of 10 using the technique described previously.28
To confirm and determine the percentage of infection, virus antigen expression was determined 24 hours and 48 hours postinfection (PI) by FACScan analysis using indirect immunofluorescent staining with anti-CMV monoclonal antibodies (MoAbs). As primary antibodies we used monoclonal mouse anti-CMV (DAKO-CMV CCH2; Dakopatts, Gloustrup, Denmark) and mouse anti-CMV late antigen MoAb (Chemicon, Temecula, CA). The secondary antibodies were goat antimouse Ig fluorescein conjugate and rat antimouse K phycoerythrin conjugate (Becton Dickinson). We consistently achieved infection rates between 50% and 70%. In an effort to determine which component(s) of the viral stock was responsible for the observed effects on IL-6 expression, we included all of the following groups at each time point: complete virus Stock; UV-inactivated viral stock, prepared as previously describedz9; vi- increase until our last time point at 48 hours. IL-l -stimulated cells were used as our positive control, but the levels of IL-6 produced by these never reached levels of CMV-induced production. Intracellular stores were measured as described and found to be negligible. Furthermore.
cycloheximide at a concentration of 10 pg/mL was able to completely block IL-6 production as shown at the 2-and 4-hour time points.
rus stock that had been heat-inactivated for 15 minutes at 70°C; and the supernatant and the viral pellet (resuspended in culture medium) from virus stock that was ultracentrifuged for 2 hours at 100,OOOg. These cleared supernatants and both the heat-inactivated and UV-treated viral stocks were confirmed to be free of infectious virus by plaque assay. All these viral preparations were tested and found to be negative for endotoxin contamination by the method described above.
Cytokines and anficyfokine anfibodies. AI1 of the recombinant cytokines and anticytokine antibodies used in these studies are commercially available and are listed below with the company from which they were purchased. Recombinant human IL-la (Genzyme Corp, Boston, MA), anti-lL-la + fl ( IL-6 irnrnzmoussuy. A double-antibody sandwich enzymelinked immunosorbent assay (ELISA) for the quantitative determination of human IL-6 in tissue culture media was performed on the stored supernatants, according to the manufacturer's recommended procedure (R & D Systems) with a detection limit of 4 pgl mL.
Concentration of IL-6 in the HUVEC supernatants was deter- mRNA srudies. Total cellular RNA was obtained by the improved Peppel and Baglioni method.m Equal amounts of RNA were subjected to gel electrophoresis ( I .2% agarose, 6.6% formaldehyde). RNA was transferred to Gene Screen Plus membrane (Dupont, Boston, MA) and cross-linked under UV light.
Membranes were prehybridized overnight at 42'C according to the standard protocol accompanying the Gene Screen Plus; in short, 5X SSPE, 5X Denhardt's, 100pglmLsalmon sperm DNA, and 50% deionized formamide were used. The following morning, 1 ,OO0,000 cpm of'*P IL-6 probe were added per milliliter of prehybridization solution. Dextran sulfate (50% stock solution) was added to a final concentration of 10% to increase the specific activity of the probe. Blots were then hybridized overnight at 42°C and washed and autoradiography was conducted. To control for loading, transfer, and integrity of RNA, the blot was stripped and reprobed with glyceraldehyde-3-phosphate dehydrogenase (G-3PDH). Cytokines known to induce 11-6 are not responsible for observed effects. HUVECs were treated with CMV viral stock alone or in the presence of antibodies to IL-la, IL-1B. TNFa, and 11-4, at concentrations known to eliminate 99% of the biologic activity of their respective cytokines. Anti-IL-l ( I and anti-IL-lg had no effect on the IL-6 production, nor did anti-IL-4. The antibody to TNFu, in contrast, appeared to hold the level of 11-6 production constant at the 4-hour time point, inhibiting the later gradual increase seen at 8 and 12 hours in the cultures treated with CMV alone. DNA probes. The IL-6 cDNA probe (1.3 kb, Hindlll-Xho I) was derived from plasmid pGeM2. The G-3PDH probe is a purified I . 1-kb cDNA fragment (ClonTech Lab, Palo Alto, CA).
RESULTS

CMV stimulates release OfIL-6 from culwed HUVECs.
In an effort to determine if CMV infection has any effect on the production of IL-6 by HUVECs, we used an ELISA Kit to compare the levels of IL-6 present in the conditioned media of unstimulated HUVECs to that of HUVECs infected with CMV or treated with IL-l (20 U/mL).
IL-1 was included in our studies because it has previously been shown that IL-l at this concentration is a potent inducer of IL-6 production by cultured HUVEC.'8*2'*22 As shown in Fig I, IL-I induced a time-dependent production of IL-6 that was evident as early as 4 hours, and was still increasing at our last sampling point of 48 hours.
In contrast, CMV was able to induce a 100-fold increase ( 1 0 0 pg/mL) in thc amount of active IL-6 present in the supernatant at only 7 hours whcn compared with both untreated and IL-I-stimulatcd HUVEC. This initial transient burst in production was followed by a much slower. timedependent response that became discernable at 8 hours and was still increasing at 48 hours. The possibility that this early observation was caused by Contamination of the viral stock with minute quantities of endotoxin not detectable by the Limulus test was rulcd out by the obscrvation that polymyxin B at a Concentration of 10 pg/mL was unable to block the production of IL-6" (data not shown). To show that this rapid increase in IL-6 production was not caused by the release of intracellular stores. untreated HUVECs were scraped from the culture dish and subjected to three freeze thaw cycles. centrifugcd to pcllet debris. and analyzed in the same way." Furthcrmore. cycloheximide at a concentration of 10 pg/mL was able to completely block IL-6 production.
['I ' / r c~~/ t m w / r?f' virus .s/r)c.k crhro)g(~/c~.s i1.s crhili/y 1 0 incrcwc' IL-6. The next issuc we wished to address was whether the prcsencc of infectious virus was essential for the induction of IL-6 to occur. To accomplish this. we repeated thc abovc cxpcrimcnts. this timc including UV-inactivated viral stocks. As can be secn in Fig 2. UV treatment of the viral stock almost completely eliminated the stimulatory effect of the stock.
This led us to thc prcliminary conclusion that virus infection was indeed necessary for induction of IL-6. To further elucidate the mechanism ofthe CMV-induced IL-6 production. we conducted another set ofexperiments usingcleared supernatantsand the viral pellet from ultracentrifuged virus stocks. The results from these experiments. which arc shown in Fig 3. provcd conclusively that the virus was in fact not the component of the viral stock responsible for the early increased production of IL-6 in cultured HUVECs. The virus alone was only able to induce an increase in the production of IL-6 at a later time point. starting at 12 hours. and never reaching the levels of induction seen with the viral cleared CMV stock. Rather. it wasa soluble factor(s) present in the supernatant of the virus stock that was eliciting the obscrvcd response. Further. WC could conclude that this factor wassensitivc to U V light because treatment ofviral stock alone with UV light removed its ability to induce IL-6 production. Also. this factor was shown to be heat labile because treatment at 70°C for IS minutes completely abolished its effcct on IL-6 production in HUVECs (data not shown).
C)~/rkirlc.s ktlo1c.11 11) ir1tiuc.c. 11.4 arc' rc~.spotuihIc~.fi)r ohscr~*c~ci c;/li'c./.v.
Our next set of experiments was designed with the purpose of showing that the IL-6 induction we observed was not caused by the presence of IL-I a. IL-18. IL-4. or TNFn. cytokines that have all previously been reported to increase production of IL-6 in cultured HUVEC. The initial burst obscrvcd at 2 hours could not be caused by any of these Factors. as even IL-I. which has the fastest action on IL-6 production. does not really exert any great effect until around 6 hours. However. thc slower. time-dcpendent response we obscrvcd could. in Fact. be caused by one of these factors. To this end. WC treated HUVECs with CMV viral stock alone and in the presence of antibodies to IL-I m. IL-18. TNFn. and IL-4. These antibodies were all used at concentrations reported by the manufacturers to neutralize greater than 99'"' of the biologic activity of their respective cytokinc. Anti-IL-ltr was added at a sufficient concentration to block 10.000 pg of IL-ltu. anti-lL-I8 was added to block 20.000 pg of IL-ILj. anti-IL-4 was added to block 4.500 pg of IL-4. and antihuman TNFtu was added to block 250 pg of TNFtr. As cxpcctcd. none of the antibodies had any significant inhibitory effcct on the burst in IL-6 production seen at 2 hours.
Somewhat surprisingly. the antibodies to IL-In. IL-18.
and IL-4 had no significant effect on the delayed induction of IL-6. The antibody to TNFtr. in contrast, appeared to hold the level of IL-6 production constant at the 4-hour time point. inhibiting the gradual increase seen in the untreated supernatant cultures at 8 and 17 hours (Fig 4) . Increasing the antibody concentrations to twice the neutralizing dose yielded the same results (data not shown). 
H U V E C s were analyxd at various time points PI. mRNA isolated from IL-l-treated I-IUVECs (6 hours posttreatment) served as a positive control (Figs 5 and 6) .
As shown by densitometric analysis in Fig 7. untreated H U V E C s produced a fiirly appreciable quantity of IL-6 nlRNA. However. C M V stock induced a rapid 1.81-fold (81''; ) increase in IL-6 mRNA. which was easily dctectablc at our tirst sampling point of 30 minutes. The levels of IL-6 mRNA remained elevated for the next 3 hours. only to undergo a pronounced 3.4-fold increase bctwccn the 3-hour and h-hour time points. In fact. by the 6-hour time point. the lcvcls of IL-6 mRNA were similar t o those present in the IL-l-treated HUVECs.
Because it was previously shown that the 11. 4 gene is capable of being transcriptionally activated by a variety of biologic Factors without the prior need for protein synthcsis.' we in\.cstigatcd whether C M V itself or a factor in the supernatant o f C M V stocks was capable of eliciting a rcsponsc ofthis type. To this end. H U V E C s were pretreated for 1 llourwithcyclohcximide( IOpg/mL)and then rcccivcd either C M V stock or supernatant from viral stock. both of which contained IOpg/mL ofcyclohcximidc. At Northern blot analysis of G-3PDH mRNA levels for normalization of RNA loading. The Northern blot shown in Fig 5 was stripped and reprobed with a G-BPDH-specific probe to assess the consistency of RNA loading. Densitometric analysis was performed, and all samples were normalized to correct for the small well-to-well discrepancies observed. These corrected values were then used to evaluate the changes in the levels of IL-6 mRNA.
Furthermore. the levels of IL-6 mRNA induced by the supernatant alone were equal to or greater than those induced by the complcte viral stock. supporting the notion that this rapid induction is caused by a factor in thc supcrnatant rather than the virus itself.. The aim ofthis study was to show that ECscould be modulated by H C M V with respect to production of hcmatopoietic cytokincs. IL-6 belongs t o a complex cytokinc nctwork that is involved in regulation o f both hematopoiesis and inflammation: for this reason. it was chosen as the focus ofthis study. The data presented here show that H C M V stocks arc able to induce a 100-fold increase in IL-6 production detectable as early as 2 hours PI at the protein level and at 30 minutes at the message (mRNA) Icvcl. 
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This initial transient burst gave way to a slower, more progressive increase evident at later time points. Such a rapid increment has previously been shown in a system in which HCMV was shown to activate transcription of the cellular oncogenes c-fos, c-jun, and c -r n y~?~.~~ to maximal levels in under 1 hour. This finding, coupled with the striking similarity between the transcriptional regulatory regions of the IL-6 gene and that of c-jios,' makes this rapid induction of IL-6 mRNA and protein feasible. Because sodium butyrate is known to increase the intracellular level of cAMP and it has previously been shown that the IL-6 gene contains the sequences for two important regulators of transcriptional activity, serum responsive element (SRE) and cAMP responsive element (CRE), the possibility that either of these factors was responsible for our observation had to be ruled out. To eliminate these variables, all of our controls were also pretreated for 24 hours with sodium butyrate and all controls and samples received fresh media at time 0. The effect of these factors on IL-6 production in HUVECs was negligible.
To determine if infection was necessary for the induction of IL-6, we used UV-treated, heat-inactivated, viral stock cleared of virus and viral pellet. From these studies, we were able to conclude that the early effect first described was caused by a factor(s) in the viral cleared supernatant, and that this effect decreased rapidly, but began to increase again at 8 hours. The CMV viral pellet by itself could only induce a late increase starting at 12 hours that never reached the levels of induction seen with the viral cleared supernatants or with the complete viral stock. The heat-inactivated virus was not able to elicit any response, indicating that the factor(s) is heat labile.
UV-treated CMV, on the other hand, had some effect at time points greater than 12 hours, but never induced any significant production of IL-6. In an effort to clarify the mechanism by which the stock virus and the cleared viral stock were producing this early effect, we addressed whether this induction was simply caused by the presence in the viral supernatants of IL-1 cy, IL-1 p, TNFa, or IL-4, all previously shown to be inducers of IL-6 in ECs. This was definitively ruled out by the inability of the appropriate neutralizing antibodies to abrogate the production of IL-6.
Furthermore, the possibility that endotoxin was contaminating the viral stock and was responsible for the observed effects was eliminated by showing that polymyxin B was unable to decrease the production of IL-6 in response to the viral supernatant.
Although the factor(s) in the supernatant that is responsible for the induction of IL-6 is as yet unknown, additional studies are currently under way to further characterize and identify this factor, as well as to elucidate the mechanism by which the virus is inducing the delayed production of IL-6.
It is interesting to note that the data in these studies are in keeping with the recent report of Segal et al,34 who found that supernatants of human immunodeficiency virus 1 stocks were capable of inducing IL-6 production in cultured ECs.
Our in vitro studies show that CMV is capable ofworking either directly by infecting the target cells or indirectly by inducing a soluble factor(s) that ultimately causes an alteration in cytokine production by these cells. In this way, the effects of CMV infection with respect to hematopoiesis could be much more far reaching, as CMV is able to modulate the production of hematopoietic cytokines, regardless of whether the cells producing these factors are infected or even exposed directly to the virus itself. For personal use only. on November 11, 2017. by guest www.bloodjournal.org From
